SRX Global regains NYSE American listing compliance; resolves Section 1003(a)(i) and (ii) deficiency

SRx Health Solutions, Inc.

Received NYSE American notice on July 15, 2026 confirming compliance with continued listing standards.
Resolved deficiency under Section 1003(a)(i) and (ii) of the NYSE American Company Guide, originally cited in October 2025.
Compliance indicator ".BC" will be removed; company removed from noncompliant issuer list.
No financial impact or other material changes disclosed.

Featured in Daily 8-K Digest

Selected #10 for 2026-07-16. Read digest

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.